PATRONO, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 1.987
EU - Europa 1.675
AS - Asia 1.192
SA - Sud America 33
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 4.898
Nazione #
US - Stati Uniti d'America 1.981
SG - Singapore 389
CN - Cina 388
UA - Ucraina 366
IE - Irlanda 312
TR - Turchia 296
SE - Svezia 253
GB - Regno Unito 206
FR - Francia 142
DE - Germania 136
IT - Italia 93
IN - India 92
FI - Finlandia 85
RU - Federazione Russa 59
BR - Brasile 27
BE - Belgio 7
CA - Canada 5
EU - Europa 5
IL - Israele 5
CZ - Repubblica Ceca 4
IR - Iran 4
NL - Olanda 3
PL - Polonia 3
TW - Taiwan 3
AR - Argentina 2
AT - Austria 2
EG - Egitto 2
IQ - Iraq 2
UY - Uruguay 2
AU - Australia 1
BN - Brunei Darussalam 1
CG - Congo 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HK - Hong Kong 1
ID - Indonesia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
MA - Marocco 1
MT - Malta 1
MX - Messico 1
NO - Norvegia 1
NP - Nepal 1
PK - Pakistan 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
VE - Venezuela 1
VN - Vietnam 1
Totale 4.898
Città #
Jacksonville 411
Chandler 365
Dublin 310
Singapore 305
Southend 172
Izmir 147
Princeton 143
Wilmington 105
Nanjing 102
Dearborn 75
Santa Clara 75
Beijing 72
Ashburn 67
Cambridge 67
Ann Arbor 41
Nanchang 36
Woodbridge 35
Altamura 29
Shenyang 23
Kunming 21
Helsinki 19
Boardman 18
Jiaxing 18
Grevenbroich 17
Hebei 17
Changsha 15
Washington 15
Augusta 13
Norwalk 13
Chieti 12
Houston 12
Los Angeles 12
Moscow 12
Tianjin 12
Munich 11
New York 10
San Mateo 10
Falls Church 9
Hangzhou 9
Orange 8
Brussels 7
Jinan 7
Lanzhou 7
Leawood 7
Seattle 6
Shanghai 6
Zhengzhou 5
Brno 4
Hackney 4
Hefei 4
Taiyuan 4
Tavagnacco 4
Toronto 4
Guangzhou 3
Kocaeli 3
Mountain View 3
Pune 3
San Jose 3
Taipei 3
Tappahannock 3
Baghdad 2
Bologna 2
Changchun 2
Chaoyang 2
Haikou 2
Istanbul 2
Kraków 2
Lanciano 2
Lucca 2
Montevideo 2
Ningbo 2
Perugia 2
Rome 2
Santos 2
Secaucus 2
Simi Valley 2
Spoltore 2
Teramo 2
Adelaide 1
Algiers 1
Americana 1
Auburn Hills 1
Bandar Seri Begawan 1
Bangalore 1
Bekasi 1
Belgrade 1
Bellante 1
Belo Horizonte 1
Bishkek 1
Brazzaville 1
Buffalo 1
Cairo 1
Capistrano 1
Catania 1
Chicago 1
Chongqing 1
Clearwater 1
Curvelo 1
Damanhur 1
Denizli 1
Totale 3.011
Nome #
Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer. 127
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 118
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 116
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 107
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 105
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 101
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 99
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 94
null 93
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 88
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 84
Insulin resistance as a determinant of platelet activation in obese women. 82
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 82
Aspirin, platelet inhibition and cancer prevention. 82
Determinants of platelet activation in Alzheimer's disease 81
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 80
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 80
Cyclooxygenase-2 expression and inhibition in atherothrombosis. 79
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 79
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 78
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 77
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 76
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 76
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 76
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 76
Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury? 75
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 74
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 73
Increased thromboxane biosynthesis in essential thrombocythemia 72
Nutraceuticals in diabetes and metabolic syndrome. 72
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 71
Soluble CD40L as an indicator of platelet Activation in Heart Failure 71
Role of Platelet Activation in Dementia 70
Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. 70
Effects of nabumetone on prostanoid biosynthesis in humans. 69
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 68
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. 68
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 68
Mechanisms, consequences, and prevention of coronary graft failure 68
Insulin resistance as a determinant of platelet activation in obese women 66
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 66
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 65
Determinants of platelet activation in human essential hypertension. 65
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 64
Platelet activation in obese women: role of inflammation and oxidant stress. 64
Drugs, prostaglandins, and renal function. 64
Insulin resistance as a determinant of platelet activation in obese women 62
Antiplatelet agents in the prevention of diabetic vascular complications 62
Determinants of Platelet Activation in Heart Failure. 61
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 61
Cyclooxygenase-2 expression and inhibition in human monocytes 61
Short term Vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects. 60
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 60
Determinants of Platelet Activation in Heart Failure. 60
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 60
Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prosta-glandin endoperoxide synthases 59
Effects of successful weight loss or pioglitazone on thromboxane-dependent platelet activation in obese women 58
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors 58
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 57
In vivo formation of 8-isoprostaglandin F-2 alpha and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation 56
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 56
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 54
Thromboxane biosynthesis in cardiovascular diseases 54
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 51
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective 51
Increased thromboxane biosynthesis in type IIa hypercholesterolemia 50
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 49
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 48
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man 42
In vivo platelet activation in diabetes mellitus 35
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 30
Off-pump coronary artery bypass grafting: 30 years of debate 12
Platelet-specific deletion of cyclooxygenase-1 ameliorates dextran sulfate sodium-induced colitis in mice. 4
Totale 5.050
Categoria #
all - tutte 21.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.018


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020194 0 0 0 0 0 0 0 0 18 81 95 0
2020/2021456 70 1 72 1 26 100 3 4 79 70 10 20
2021/2022275 1 4 6 47 26 5 7 18 25 9 41 86
2022/2023989 81 129 80 98 89 211 57 62 125 13 19 25
2023/2024417 32 10 31 13 30 113 126 18 2 3 5 34
2024/2025770 95 283 202 16 9 41 12 29 83 0 0 0
Totale 5.050